Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
01/12/2010 | CA2443365C Methods for the recombinant production of antifusogenic peptides |
01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
01/12/2010 | CA2340974C Method for purifying proteins and/or biomolecule or protein complexes |
01/12/2010 | CA2293731C Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use |
01/12/2010 | CA2290217C Peptides for the detection of hiv-1 group o |
01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
01/12/2010 | CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
01/07/2010 | WO2010002862A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
01/07/2010 | WO2010002468A1 A functional complementation assay for defined gpcr oligomers |
01/07/2010 | WO2010002042A1 Enzyme substrate for labeling of protein |
01/07/2010 | WO2010001960A1 Method for production of recombinant protein by using genetically engineered brevibacillus bacterium |
01/07/2010 | WO2010001908A1 Anti-cd27 antibody |
01/07/2010 | WO2010001659A1 Method for production of preparation containing single useful substance having polypeptide |
01/07/2010 | WO2010000025A1 Anti-pamp therapeutic antibodies |
01/07/2010 | WO2009140348A3 Anti-il-6/il-6r antibodies and methods of use thereof |
01/07/2010 | WO2009137677A3 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus |
01/07/2010 | WO2009134368A3 Methods of producing bacterial alginates |
01/07/2010 | WO2009123950A3 Chimera comprising bacterial cytotoxin and methods of using the same |
01/07/2010 | WO2009123894A3 Her2/neu-specific antibodies and methods of using same |
01/07/2010 | WO2009100255A3 Modified leptin polypeptides and their uses |
01/07/2010 | WO2009076292A3 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome |
01/07/2010 | WO2009064944A3 Antibodies to lrp6 |
01/07/2010 | WO2008097870A3 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
01/07/2010 | US20100005543 Toxin genes and methods for their use |
01/07/2010 | US20100005536 Promoter for Introducing a Gene into a Lymphocyte or Blood Cell and Application Thereof |
01/07/2010 | US20100004433 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
01/07/2010 | US20100004429 Agonist antibody to human thrombopoietin receptor |
01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
01/07/2010 | US20100004183 Mineral collagen chelates and methods of making and using same |
01/07/2010 | US20100004175 Novel bmp-12-related proteins and methods of their manufacture |
01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
01/07/2010 | US20100003722 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields |
01/07/2010 | US20100003721 Human interferon-beta mutein |
01/07/2010 | US20100003720 Enzyme derived from thermophilic organisms that functions as a chromosomal replicase, and preparation and uses thereof |
01/07/2010 | US20100003719 Trimerising Module |
01/07/2010 | US20100003718 Method and apparatus for the production of soluble mhc antigens and uses thereof |
01/07/2010 | US20100003682 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
01/07/2010 | US20100003673 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
01/07/2010 | US20100003365 Cloning, expression and use of acid phospholipases |
01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
01/07/2010 | US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
01/07/2010 | DE102008032828A1 Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel Tryptophan-containing peptides from alpha-lactalbumin with antihypertensive and vasoprotective effect for biofunctional food |
01/07/2010 | CA2729567A1 Anti-cd27 antibody |
01/06/2010 | EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins |
01/06/2010 | EP2141175A1 Process for synthesizing cyclic peptide compound |
01/06/2010 | EP2141174A1 Column packing and column for refolding protein |
01/06/2010 | EP2141120A1 High throughput discovery of materials through vapor phase synthesis |
01/06/2010 | EP2140268A1 Method for controlling glucose uptake and insulin sensitivity |
01/06/2010 | EP2140147A2 Clip-on, clip off mounting device as for a portable light |
01/06/2010 | EP2140015A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
01/06/2010 | EP2140008A2 Yeast expression systems |
01/06/2010 | EP2139996A1 Peptidases from basidiomycetes |
01/06/2010 | EP2139986A1 Use of low temperature and/or low ph in cell culture |
01/06/2010 | EP1824986B1 Biomaterial which can successively carry out a solution/gel transition then a gel/solution transition |
01/06/2010 | EP1476562B1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
01/06/2010 | EP1432722B1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
01/06/2010 | EP1409018B1 Stable lyophilized pharmaceutical formulation the igg antibody daclizumab |
01/06/2010 | EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
01/06/2010 | CN101619339A Production method of bacterial exotoxin |
01/06/2010 | CN101619338A Method for producing genistein protein powder by using natto bacilli to ferment soybean meal |
01/06/2010 | CN100577809C Enzymes having alpha amylase activity and method of use thereof |
01/06/2010 | CN100577804C Novel mutant allergens |
01/06/2010 | CN100577682C Method for designing and preparing small peptide |
01/05/2010 | US7642345 Polynucleotides encoding human cytokine receptor |
01/05/2010 | US7642341 Antibody fragments are selected from Fab fragments, Fv fragments, single domain antigen binding fragments, scFv and aggregates thereof; for treatment of solid tumor carcinomas |
01/05/2010 | US7642236 Recombinant lubricin molecules and uses thereof |
01/05/2010 | US7642228 Method for making heteromultimeric polypeptides |
01/05/2010 | US7642083 Generation of hydroquinone and derivatives; obtain quinic acid, oxidize to 3,4,5-trihydroxycyclohexanone, convert 3,4,5-trihydroxycyclohexanone to hydroquinone |
01/05/2010 | US7642081 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
01/05/2010 | US7642078 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally; glycosylation of recombinant proteins when produced in adenovirus E1A-expressing cells |
01/05/2010 | US7642072 Optimized interferon-beta gene |
01/05/2010 | US7642071 Expressing Gram-negative glycosaminoglycan synthase gene in a Gram-positive bacterial host background to produce GAGs by fermentation in vivo; providing a purified nucleic acid segment encoding an enzymatically active chondroitin synthase |
01/05/2010 | US7642069 Process for the intracellular over-production of streptokinase using genetically engineered strain of E. coli |
01/05/2010 | US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
01/05/2010 | US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide |
01/05/2010 | US7641904 IL-32 monoclonal antibodies and uses thereof |
01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
01/05/2010 | US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 |
01/05/2010 | CA2592555C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
01/05/2010 | CA2381995C Method for the production of proteinaceous substances |
01/05/2010 | CA2290717C Nucleic acid binding proteins |
01/05/2010 | CA2281877C Psca: prostate stem cell antigen |
01/05/2010 | CA2234119C Improved barstar gene |
01/05/2010 | CA2184636C Immunoenzymatic conjugate, preparation method therefor and uses thereof |
01/05/2010 | CA2182810C Bacteriocin from micrococcus varians |
01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
12/31/2009 | US20090328259 Polypeptides having endoglucanase activity and polynucleotides encoding same |
12/31/2009 | US20090328254 Novel vip3 toxins and methods of use |
12/31/2009 | US20090328251 Galactosyltransferase |
12/31/2009 | US20090328249 Transplastomic Plants Expressing Lumen-Targeted Protein |
12/31/2009 | US20090326204 Interferon-like protein zcyto21 |
12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
12/31/2009 | US20090325875 Muteins of human tear lipocalin |
12/31/2009 | US20090325873 Human glp-1 mimetibodies, compositions, methods and uses |
12/31/2009 | US20090325866 Non-activated wnt inhibition polypeptides and method for preparing the same |